Alumis Share Price

Alumis Share Price

NASDAQ: ALMS | Small Cap | Healthcare
$3.98
-$0.35 (-7.99%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Alumis Stock Performance

Open
$4.24
Prev. Close
$4.32
Circuit Range
N/A
Day Range
$3.94 - $4.37
Year Range
$3.94 - $31.30
Volume
70,239
Average Traded
$4.05

Alumis Share Price Today

As of 23 November 2026, Alumis Inc.'s share price is $3.98. The stock opened at $4.24, compared to its previous close of $4.32. During today's trading session, Alumis Inc.'s share price traded between $3.94 and $4.37, with an average price of $4.15. Over the past 52 weeks, the stock has recorded a high of $31.30 and a low of $3.94. In terms of performance, Alumis Inc.'s share price has declined by 81.59% over the last six months and is down 48.21% on a year-on-year basis.

Alumis Share Price Chart

Line chart of the Alumis price trend over the selected period. The price fell overall, ranging from 3.94 to 4.37, ending at 3.98.
$3.94$4.37
L
Show Current Price
H

Alumis Stock Fundamentals & Key Indicators

Market Cap
$337.99M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-3.26
Revenue (TTM)
$24.05B
Return On Equity (TTM)
-111.85%
Profit Margin
-1011.77%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-1.88%

Alumis Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$1.93$1.74$1.66$1.91
Net Profit-$93.13-$93.05-$142.22-$94.88
Net Profit Margin-4825.39%-5347.70%-8567.47%-4967.54%
Income ChangeN/A0.09%-52.84%33.29%

Alumis Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$0.00$24.05
Net Profit-$294.23-$243.33
Net Profit MarginN/A-1011.77%
Income ChangeN/A17.30%

Alumis Balance Sheet

All figures in USD Million

Particulars20252024
Non Current Assets93.7134.8
Current Assets318.23306.19
Total Assets411.94340.99
Non Current Liabilities37.3329.98
Current Liabilities73.3250.91
Total Liabilities110.6480.89
Shareholders' Equity301.3260.1

Alumis Cash Flow

Annually

All figures in USD Million

Particulars20252024
Operating-369.52-255.08
Investing287.88-113.79
Financing2.07492.37

About Alumis

Alumis Inc is a clinical-stage biopharmaceutical company with an initial focus on developing its two Tyrosine Kinase 2 ("TYK2") inhibitors: envudeucitinib ("envu"), an allosteric TYK2 inhibitor for the treatment of PsO and SLE; and A-005, a central nervous system ("CNS") penetrant allosteric TYK2 inhibitor, to offer the therapeutic benefit of TYK2 inhibition within the CNS for a broad range of neuroinflammatory and neurodegenerative diseases.

Alumis Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$6.80
$3.96
-41.08%
Oct 2026
$7.36
$6.73
-9.12%
Sep 2026
$9.92
$7.41
-68.08%
Aug 2026
$27.25
$23.20
-17.78%
Jul 2026
$27.65
$28.21
+0.36%
Jun 2026
$20.94
$28.11
+30.17%
May 2026
$25.06
$21.59
-12.43%
Apr 2026
$23.14
$24.66
+11.94%
Mar 2026
$29.00
$22.03
-25.70%
Feb 2026
$24.48
$29.65
+20.97%
Jan 2026
$9.49
$24.51
+151.38%
Dec 2025
$7.67
$9.75
+27.04%

Alumis Share Price FAQs